Ching-Fu Lien

Experience

• 

  TOLL GLOBAL FORWARDING (USA) INC.

  Mar 2007 - Jul 2012

  Credit Analyst

  Evaluate and analyze prospective customers’ financial information and recommended credit limit as well as payment terms. Manage full cycle of AR and AP. Reconcile inter-company accounts receivable and accounts payable with foreign subsidiaries. Prepare annual budget for regional offices. Assist with internal and external audits.Key results:•Analyze 100+ accounts to discover discrepancies and resolve all variance promptly.•Saved company 28% in leasing costs and resolved charges which had been under dispute for more than a year. Show less

• 

  BizLink Group

  Jul 2012 - May 2016

  Accountant

  A leading provider of interconnect solutions with over 10,000 employees, specializing in the design, manufacture, and sale of cable assemblies, connectors, power cords, fiber optical passive components, and computer peripheral products with approximately $1.7 billion in annual revenue.Collaborated with upper management on budgets and forecasts. Conducted internal and facilitated external audits for policy compliance. Completed annual financial requirements, including tax filings and license renewals. Prepared and evaluated monthly balance sheets, P&L, cash flow statements, and general ledger accounts.• Successfully resolved numerous disputed charges, reducing past-due balances by 16%.• Procured an online credit card payment service, greatly increasing payment efficiency.• Generated dynamic spreadsheets with custom formulas, cutting weekly report processing time by 50%.•Led a team in filing an exemption claim pursuant to the Harmonized Tariff Schedule (HTS), substantially reducing total import tax up to $10K. Show less

• 

  Crown Bioscience, Inc.

  May 2016 - Oct 2021

  Senior Accounting Manager

  A global contract research organization (CRO) with over 1000 employees specializing in preclinical and translational research services to accelerate drug discovery and development with approximately $170 mm in annual revenue.Led the accounting team in managing financial activities, including month-end closing and financial statement preparation. Ensured GAAP compliance for revenue recognition and internal controls. Measured financial performance against budgets and business plans. Developed procedures and tools to enhance productivity and department workflow.• Created new accounting procedures and implemented ERP software, reducing monthly closing processes by five days.• Introduced a process to engage clients and resolve long-standing open invoices, reducing Accounts Receivables by 95% within two months.• Built and maintained a web dashboard for key performance indicators, increasing overall financial awareness in the department.•Proactively consulted business advisors and subsequently implemented Oracle software that successfully facilitated compliance with Initial Public Offering (IPO) requirements of the Taiwan Stock Exchange. Show less

• 

  JSR Life Sciences

  Oct 2021 - May 2024

  Financial Planning and Analysis Manager

  A multinational advanced materials and solutions company with over 2500 employees specializing in providing advanced products, materials, and services for biopharmaceutical companies and academic researchers with approximately $700mm in annual revenue. Evaluated financial performance against budgets and forecasts, providing variance analysis. Developed the annual budget and periodic forecasts to align with strategic goals. Collaborated with senior management and department heads to gather budget input and provide financial guidance. Oversaw the consolidation team, fostering a skilled workforce to achieve superior results.• Streamlined revenue reporting and P&L generation by creating a standardized template and utilizing Excel Power Query to build a Data Lake, reducing process time from two days to half a day and cutting errors by 66%.• Enhanced strategic decision-making by forecasting financial statements (P&L, Balance Sheet, Cash Flow) for multiple business lines and legal entities, consolidating them to produce unified global financial statements for the life sciences sector, significantly improving ROI evaluation. Show less